Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**BSS Plus** is a preservative-free, sterile intraocular irrigating solution manufactured by Alcon for maintaining a physiologic ocular environment during intraocular surgery. The two-part product is reconstituted immediately before use and contains electrolytes, bicarbonate, dextrose, and oxidized glutathione. It has no discrete molecular target; its intended effect is physicochemical support of ocular tissues by providing an intraocular perfusate with ionic composition, pH buffering, nutrients, and antioxidant capacity suitable for procedures including pars plana vitrectomy, phacoemulsification, cataract extraction or lens aspiration, and anterior-segment reconstruction. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=f69655c5-cf32-6461-e00e-3a5c4a761344))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on BSS Plus.